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The paramyxovirus fusion protein (F) promotes fusion of the viral envelope with the plasma membrane of target cells as well as cell–cell
fusion. The plasma membrane is closely associated with the actin cytoskeleton, but the role of actin dynamics in paramyxovirus F-mediated
membrane fusion is unclear. We examined cell–cell fusion promoted by two different paramyxovirus F proteins in three cell types in the presence
of constitutively active Rho family GTPases, major cellular coordinators of actin dynamics. Reporter gene and syncytia assays demonstrated that
expression of either Rac1V12 or Cdc42V12 could increase cell–cell fusion promoted by the Hendra or SV5 glycoproteins, though the effect was
dependent on the cell type expressing the viral glycoproteins. In contrast, RhoAL63 decreased cell–cell fusion promoted by Hendra glycoproteins
but had little affect on SV5 F-mediated fusion. Also, data suggested that GTPase activation in the viral glycoprotein-containing cell was primarily
responsible for changes in fusion. Additionally, we found that activated Cdc42 promoted nuclear rearrangement in syncytia.
© 2006 Elsevier Inc. All rights reserved.Keywords: Paramyxovirus; Membrane fusion; Rho GTPase; Actin; GlycoproteinIntroduction
The paramyxovirus family contains a number of important
human pathogens, including measles, mumps, and respiratory
syncytial virus (RSV), as well as the recently emerged Hendra
and Nipah viruses. Hendra virus was first detected in a
population of horses in 1994 and later in the horses' human
caretakers. Of three known human infections, two were fatal
(Murray et al., 1995; Paterson et al., 1998). Autopsy revealed
multinucleated giant cells in several of the patients' organs
(O'Sullivan et al., 1997; Paterson et al., 1998). Hendra virus
was placed in a new genus, Henipavirus, together with Nipah
virus, another deadly emergent zoonotic virus that causes
multinucleate giant cells in patient tissue (Bellini et al., 2005;
Harcourt et al., 2000; Wang et al., 2000). SV5, a paramyxovirus
of the Rubulavirus genus, infects humans asymptomatically and
causes respiratory infection in dogs (Goswami et al., 1984;⁎ Corresponding author. Fax: +1 859 323 1037.
E-mail address: rdutc2@uky.edu (R.E. Dutch).
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doi:10.1016/j.virol.2006.01.033McCandlish et al., 1978). Paramyxoviruses have a host-derived
lipid envelope that must fuse with a host membrane to deliver
viral genetic material into the cell. This fusion event is
independent of pH and can take place at the plasma membrane
for all paramyxoviruses studied to date (Dutch et al., 2000).
Paramyxoviruses express fusion (F) and attachment (G/HN/H)
glycoproteins on their surfaces, both of which are required for
efficient entry (Lamb and Kolakofsky, 2001). Paramyxovirus
infected cells also express these glycoproteins on the plasma
membrane. As a result, infection by some paramyxoviruses,
including Hendra virus and SV5, results in fusion of host cells
and the formation of multinucleated giant cells or syncytia.
There is potential for viruses entering at the plasma
membrane to be affected by the actin cytoskeleton, since actin
is closely associated with the membrane through both
connections to the membrane and to membrane-associated
proteins (Bretscher, 1991; Lodish et al., 2000). Furthermore,
actin is arranged in a dense meshwork, known as the cortical
cytoskeleton, just beneath the plasma membrane (Small et al.,
1995; Weed and Parsons, 2001). Actin is intimately involved in
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While mediating these tasks, actin exerts force on the membrane
and affects membrane curvature. Additionally, actin is involved
in cell adhesion, endo- and phagocytosis, and movement of
intracellular particles (Beckerle, 1998; Chimini and Chavrier,
2000; Mitchison and Cramer, 1996; Qualmann et al., 2000;
Ridley, 2000).
Actin filament (F-actin) assembly and disassembly are
highly dynamic and well regulated. The signaling molecules
primarily mediating the regulation of actin organization are the
Rho family GTPases (Hall, 1998; Zigmond, 1996). These
acutely regulated signaling molecules cycle between a GDP-
and GTP-bound form, in which the GDP-bound form is “off”
and the GTP-bound form is “on” (Etienne-Manneville and Hall,
2002). GTP-bound Rho family GTPases specifically activate a
variety of effector molecules, which then either propagate the
signaling cascade or directly alter actin structure (Bishop and
Hall, 2000; Weaver et al., 2003). Members of the Rho family of
GTPases differentially affect the localization and structure of
actin by altering its nucleation, polymerization, stabilization,
and larger order assembly in specific areas of the cell (Bishop
and Hall, 2000; Hall, 1998; Takai et al., 2001). The first three
Rho family GTPases identified, hence the best characterized,
are Rac1, RhoA, and Cdc42 (Ridley, 2001). These GTPases are
best known for their effects on the actin cytoskeleton, but they
are also known to activate transcription factors, facilitate cell
cycle progression, mediate secretion, and facilitate cell–cell
contacts (Bishop and Hall, 2000). Constitutively active forms of
these proteins can be created with a point mutation that results
in an inability to hydrolyze or release bound GTP, and these
mutant proteins induce a characteristic appearance of the actin
cytoskeleton (Nobes and Hall, 1995; Ridley and Hall, 1992;
Ridley et al., 1992; Schmidt et al., 1997). Conversely, a different
point mutation results in a Rho family protein that is more likely
to be nucleotide-free (referred to as a dominant negative) (Feig,
1999). These mutants bind guanine nucleotide exchange factors
(GEFs) with higher affinity than their wild-type counterparts, so
they prevent endogenous GTPase activation by sequestering
cellular GEFs.
Constitutively active Rac1 induces the formation of thin
protrusive structures called lamellipodia at the cell periphery as
well as membrane ruffles (Nobes and Hall, 1995; Ridley et al.,
1992). These structures are the product of actin polymerization
at the cortical cytoskeleton, below the plasma membrane.
Constitutively active RhoA is a potent inducer of stress fibers,
which are stiff actin bundles associated with myosin-based
contractility that terminate in focal adhesions (Ridley and Hall,
1992). RhoA is thought to work in opposition to Rac1, since it
promotes membrane retraction while Rac1 promotes membrane
protrusion. Constitutively active Cdc42 induces finger-like
projections called filopodia at the plasma membrane (Nobes and
Hall, 1995). In addition, Cdc42 has been shown to control cell
polarity (Nobes and Hall, 1999; Pruyne and Bretscher, 2000),
and very recently, it was implicated in movement of the nucleus
(Gomes et al., 2005; Lee et al., 2005).
Since paramyxoviruses enter cells at the plasma membrane
and cause adjacent cellular plasma membranes to fuse, and theplasma membrane is intimately associated with the actin
cytoskeleton, we hypothesized that changes to the cortical
actin cytoskeleton, induced by constitutively active forms of
Rho family GTPases, would affect cell–cell fusion promoted by
paramyxovirus glycoproteins. Two opposing roles for cortical
actin can be envisioned: a dense cortical actin network might
inhibit fusion by stabilizing and fortifying the cellular
membrane. Alternatively, cortical actin could cause mechanical
stress on the membrane that may increase the likelihood of
membrane merger promoted by fusion proteins.
The effect of Rho family GTPases on viral entry or cell–cell
fusion promoted by the glycoproteins of HIVand RSV has been
examined, but the conclusions drawn differed between, and
even within, these viral systems (del Real et al., 2004; Gower et
al., 2005; Pontow et al., 2004). We have examined the
promotion of cell–cell fusion by glycoproteins from two
viruses of the same family but different genera to determine if
related viral glycoproteins will be similarly affected by changes
to actin structure. We also examined fusion by both viral
glycoproteins in three mammalian cell lines to determine
whether fusion is dependent on the host cell. Using both
syncytia assays and reporter gene assays to analyze the effect of
expressing constitutively active or dominant negative forms of
Rac1, RhoA, and Cdc42 on cell–cell fusion promoted by SV5
and Hendra viral glycoproteins, we found that constitutively
active GTPases can differentially affect fusion, but the result is
indeed dependent on the cell type used as well as the viral
glycoproteins expressed. We also showed that for both
paramyxoviruses, the viral glycoprotein-expressing cell, and
not the target cell, primarily mediated the effect of the GTPase,
but this was not a consequence of changes in F protein surface
expression. Finally, our data support a recently reported novel
role for Cdc42 in nuclear rearrangement.
Results
Syncytia formation in BHK and Vero cells
The capacity for paramyxovirus glycoproteins to induce
cell–cell fusion permits the study of their fusion-promoting
activity in the absence of the whole virus. Transfection of viral
fusion and attachment genes in the pCAGGS mammalian
expression vector into monolayers of cells is sufficient to induce
cell–cell fusion, resulting in syncytia. No other viral component
is necessary for syncytia to form. Although difficult to quantify
accurately, syncytia assays allowed us to easily visualize and
compare the efficiency of fusion promotion under various
conditions. The study of cell–cell fusion is also relevant to viral
pathology, since syncytia form in host tissue during natural viral
infection (O'Sullivan et al., 1997). To observe potential changes
induced by Rho family GTPases to viral glycoprotein-mediated
fusion, the following genes were expressed in BHK cells or
Vero cells: the Hendra F and G genes or the SV5 F and HN
genes in the pCAGGS vector, along with empty vector or cDNA
for one of the three constitutively active GTPases, Rac1V12,
RhoAL63 or Cdc42V12 in a pCMV5M vector. BHK cells
(hamster fibroblast cells) were tested first because they are
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Vero cells (monkey epithelial cells) were also used to determine
whether a different cell type would give similar results with the
same combinations of viral glycoproteins and GTPases.
In BHK cells, Rac1V12 induced a clear increase in the
number and size of syncytia formed by both SV5 and Hendra
virus glycoproteins (Fig. 1A, data summarized in Table 1). An
increase in the frequency of cell–cell fusion in the presence of
Rac1V12 was especially evident with SV5 glycoproteins, as
nearly every cell in a monolayer fused by 24 h post-transfection,
eventually resulting in extensive cell death. The morphology of
syncytia that formed in the presence of Rac1V12 was different
from wild type (viral glycoproteins with empty vector).
Specifically, there appeared to be more cytoplasmic space in
syncytia, and the cell edges were rounder. Constitutively activeFig. 1. Syncytia assay. (A) Subconfluent BHK or Vero cells were transfected with SV
or Cdc42V12. Photographs were taken 20 h (SV5/BHK cells), 24 h (Hendra/BHK c
arrangement promoted by Cdc42V12 in Hendra or SV5 glycoprotein-induced syncytRhoA (RhoAL63) dramatically inhibited syncytia formation
promoted by Hendra glycoproteins. Morphological changes,
which included retracted cell edges with multiple sharp
protrusions, were only apparent in the few small syncytia that
formed and some single cells (Fig. 1A). Interestingly, RhoAL63
did not significantly inhibit SV5 F-promoted syncytia forma-
tion. The number of syncytia and the number of nuclei in the
syncytia induced by SV5 glycoproteins in the presence or
absence of RhoAL63 were not obviously different despite clear
morphological changes in most cells.
In Vero cells, the effect of the constitutively active GTPases
on Hendra glycoprotein-induced cell–cell fusion was the same
as in BHK cells: Rac1V12 increased syncytia formation and
RhoAL63 decreased syncytia formation (Fig. 1A). Interestingly,
there was no visible change by Rac1V12 or RhoAL63 on SV55 F and HN or Hendra F and G and with either empty vector, Rac1V12, RhoAL63,
ells), or 48 h (SV5 and Hendra/Vero cells) later. (B) Examples of the nuclear
ia.
Table 1
Summary of cell–cell fusion data
Hendra SV5
wt Rac1V12 RhoAL63 Cdc42V12 wt Rac1V12 RhoAL63 Cdc42V12
Syncytia assay BHK *** **** * *** *** ***** *** ***
Vero ** **** * ** * * * *
Reporter gene assay Vero 100 163 29 142 100 52 64 110
BSR ND ND ND ND 100 68 103 323
The number of asterisk (*) in a box represents the percentage of unfused cells in a field. 1 = 90–99% unfused cells, 2 = 80–60% unfused cells, 3 = 60–40% unfused
cells, 4 = 40–20% unfused cells, and 5 = 20–1% unfused cells. The value in the table is indicative of syncytia at a time when wt syncytia is optimal (∼36 h for Hendra
and ∼20 h for SV5). The numbers representing fusion in reporter gene assays are the average luminosity values (normalized to wt virus fusion set at 100%) when the
cell type indicated was the effector cell and expressed the GTPase. “ND” indicates that the experiment was not done.
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that SV5 glycoproteins alone induce syncytia very poorly in
Vero cells relative to BHK cells, making small differences
difficult to detect. These results indicate that the cell type and
the specific viral glycoprotein can affect the outcome of Rho
family GTPase activation on syncytia formation.
Syncytia assays did not reveal any major changes to the
efficiency of fusion by either set of viral glycoproteins by
Cdc42V12 (Fig. 1A). However, in syncytia formed in the
presence of Cdc42V12, nuclei formed nearly perfect rings in the
center of the majority of multinucleated cells (Fig. 1B). This
circular arrangement of nuclei are present in the syncytia
formed by glycoproteins from both Hendra and SV5 and in both
BHK and Vero cells. This suggests that Cdc42 affects nuclear
migration as syncytia formation occurs.
We also examined the effect of dominant negative Rac1,
RhoA, and Cdc42 on the promotion of cell–cell fusion by
Hendra and SV5 glycoproteins. Each of the dominant negative
GTPases affected viral glycoprotein-mediated fusion similarly,
and there was generally only a slight decrease in fusion from
wild type (data not shown). This was not entirely unexpected, as
dominant negative GTPases function by sequestering cellular
GEFs, the upstream activators of Rho family GTPases, and
many GEFs can interact with Rho family proteins promiscu-
ously (Debreceni et al., 2004). Thus, a single dominant negative
GTPase may disrupt the proper functioning of several different
GTPases. Indeed, the morphology of syncytia with each
dominant negative GTPase were indistinguishable from each
other, although different from wild type (data not shown).
Reporter gene fusion assay
To both quantify cell–cell fusion and measure it over a
shorter time period, we performed reporter gene assays. An
effector cell population (Vero cells for the initial experiments)
was transfected with plasmids containing either the Hendra or
SV5 fusion and attachment genes and luciferase cDNA under
control of a T7 promoter. BSR cells, which are BHK-derived
cells that constitutively express the T7 polymerase, were
overlayed for 3 h on the effector cells. In addition, effector,
target, or both populations were transfected with plasmids
containing a constitutively active GTPase cDNA or empty
vector. This experimental design allowed us to determine if
GTPase activation was needed in effector or target cellpopulations or both to alter fusion. Negative controls were
performed, in which effector cells lacked the fusion protein, and
background levels of fusion were approximately 7% of wild
type (data not shown).
With Hendra virus glycoproteins, a large increase in cell–cell
fusion was observed when either effector or both cell
populations were transfected with Rac1V12, but there was no
effect on fusion when only the target cell population was
transfected with Rac1V12 (Fig. 2A). This was not likely an effect
of poor transfection efficiency in BSR cells, as they formed
syncytia efficiently when they were transfected with viral
glycoproteins (data not shown). Experiments with RhoAL63-
transfected cells were also consistent with syncytia data and
indicated that the effector cell population mediated the effect of
RhoAL63 on cell–cell fusion. A decrease in fusion was
measured only when the same cells that were transfected with
the Hendra glycoproteins were also transfected with RhoAL63
(Fig. 2A). Stimulation of fusion through the effector cell by
Rac1V12 and inhibition by RhoAL63 was highly reproducible in
reporter gene assays. Cdc42V12 stimulated cell–cell fusion to
varying levels, and stimulation appeared to be mediated through
both the effector and target cell populations (Fig. 2A). The
effect of Cdc42V12 on fusion was more variable than the other
GTPases, and results depended on cell density, potentially due
to differences in cell cycle progression (data not shown).
Overall, these data are consistent with the syncytia assays in
both Vero and BHK cells showing increased Hendra F protein-
mediated fusion in the presence of constitutively active Rac1
and decreased fusion in the presence of constitutively active
RhoA.
For SV5 glycoproteins expressed in Vero cells, both Rac1V12
and RhoAL63 caused cell–cell fusion to decrease when they
were expressed in the same cell as the viral glycoproteins.
However, the extent of inhibition was only about half of that
observed with RhoAL63 and Hendra viral glycoproteins (Figs.
2A and B). In contrast, Cdc42V12 caused cell–cell fusion
mediated by SV5 glycoproteins to increase when the target cell
population was expressing Cdc42V12 (Fig. 2B). In fact, only
when target BSR cells were transfected with Cdc42V12 and
mixed with Hendra or SV5 glycoprotein-expressing Vero cells
did the target cell affect fusion. Taken together, these results
suggest that the effects of Rac1V12 and RhoAL63 on cell–cell
fusion are mediated through the glycoprotein-expressing cell,
while Cdc42V12 can play a role in the target cell. These data
Fig. 3. Reporter gene fusion assay with constitutively active GTPases; BSR
(effector) to Vero (target). Vero cells transfected with luciferase cDNA under the
control of the T7 promoter were overlayed onto BSR cells expressing T7
polymerase transfected with a GTPase or empty vector and SV5 F and HN. After
3 h, cells were lysed; the lysate was injected with luciferin and analyzed in a
luminometer. Data shown are the average of three independent experiments, and
error bars represent the standard deviation. The average luminosity measured for
wild-type SV5 fusion was 105.47.
Fig. 2. Reporter gene fusion assay with constitutively active GTPases; Vero
(effector) to BSR (target). BSR cells expressing T7 polymerase (transfected with
a GTPase or empty vector as indicated), were overlayed onto Vero cells
transfected with luciferase cDNA under the control of the T7 promoter, an empty
vector or a GTPase when indicated and (A) Hendra F and G or (B) SV5 F and
HN. After 3 h, cells were lysed; the lysate was injected with luciferin and
analyzed with a luminometer. “Effector”, “Target”, or “Both” refers to which cell
population(s) expressed the constitutively active GTPase. Data shown are the
average of three independent experiments, and error bars represent the standard
deviation; an exception to this are the Cdc42V12 data, which were averaged from
five experiments. The average luminosity measured for wild-type Hendra or
SV5 fusion was 53.43 or 48.19, respectively.
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between the paramyxovirus fusion proteins.
Syncytia assays in BHK cells strongly suggested that
Rac1V12 caused SV5 glycoprotein-mediated fusion to increase,
while reporter gene assays with Vero cells expressing SV5
glycoproteins indicated that Rac1V12 caused a slight decrease incell–cell fusion. Unfortunately, a BHK (effector) to BSR or
Vero (target) reporter gene assay could not be performed
reliably due to high background levels of fusion. Therefore, we
next performed a reporter gene assay in which the original
effector and target cell populations were reversed to determine if
the lack of significant change to SV5 glycoprotein-mediated
fusion by GTPases in Vero cells was specific to that cell type.
When BSR cells were transfected with viral glycoproteins and a
GTPase, then overlayed with Vero cells transfected with only
luciferase cDNA, we observed results that were unexpected,
considering BSR cells were derived from BHK cells. Co-
expression of SV5 F and HN with Cdc42V12 in BSR cells
enhanced cell–cell fusion by more than threefold, while
Rac1V12 and RhoAL63 had little effect on fusion (Fig. 3).
Expression of any of the three GTPases in target cells had no
effect on fusion (data not shown). When Vero cells were the
target for Hendra glycoproteins expressed in BSR cells, fusion
above background levels was not detected. This may be due to
the difference in receptor usage for SV5 and Hendra. The
Hendra receptor, ephrinB2, may be cleaved by the trypsin used
to lift target cells for overlay and then replenished slowly
(Bonaparte et al., 2005; Negrete et al., 2005).
We also examined the dominant negative GTPases, Rac1N17,
RhoAN19, and Cdc42N17, in a Vero (effector) to BSR (target)
reporter gene assay to confirm the observations we made of
syncytia expressing dominant negative GTPases. As before, a
similar decrease in cell–cell fusion was measured in the
presence of each dominant negative GTPase (Fig. 4). This was
true for both Hendra glycoprotein- and SV5 glycoprotein-
Fig. 4. Reporter gene fusion assay with dominant negative GTPases; Vero (ef-
fector) to BSR (target). BSR cells expressing T7 polymerase were overlayed onto
Vero cells transfected with luciferase cDNA under the control of the T7 promoter,
an empty vector or a GTPase when indicated and Hendra F and G or SV5 F and
HN. After 3 h, cells were lysed; the lysate was injected with luciferin and analyzed
with a luminometer. Data shown are the average of three independent experiments,
and error bars represent the standard deviation. The average luminosity measured
for wild-type Hendra or SV5 fusion was 42.63 or 45.14, respectively.
328 R.M. Schowalter et al. / Virology 350 (2006) 323–334mediated fusion, with the decrease in fusion slightly greater
with SV5 glycoproteins.
Reporter gene expression assay
In addition to their effects on actin, Rho family GTPases can
alter transcription of some genes (Bishop and Hall, 2000). ToFig. 5. Reporter gene expression assay with constitutively active GTPases. BSR
cells expressing T7 polymerase were transfected with luciferase cDNA and a
constitutively active GTPase or empty vector. The next day, cells were lysed, a 1/
100 dilution of the lysate was injected with luciferin and analyzed in a
luminometer. Data shown are the average of three independent experiments
performed in duplicate, and error bars represent the standard deviation. The
average luminosity measured for luciferase plus mock-transfected cells was 941.9.determine if the GTPases may have altered luciferase
expression in the reporter gene fusion assays, we measured
the expression of luciferase cDNA (T7 promoter) when co-
transfected with cDNA for each of the constitutively active
GTPases or vector alone into BSR cells, which constitutively
express the T7 polymerase. On average, Rac1V12 and RhoAL63
caused a 15% and 19% decrease in luciferase expression,
respectively, while Cdc42V12 caused a 5% decrease (Fig. 5).
The minor changes in luciferase expression caused by Rho
family GTPases are not consistent with changes in fusion
caused by Rho family GTPases. Thus, altered luciferase
expression is not responsible for the changes in luminosity
measured in the reporter gene fusion assays.Fig. 6. Flow cytometry analysis of F protein surface expression. BHK or Vero
cells were mock-transfected or transfected with Hendra F or SV5 F and a
GTPase or empty vector. Cell surface Hendra F or SV5 F was labeled with
primary antibody specific to Hendra F or SV5 F and a FITC-conjugated
secondary antibody. Cells were gently lifted from the plate with washing in 50
mMEDTA and fixed in 1% formaldehyde prior to analysis of fluorescence. Data
shown are the average of three independent experiments, and error bars
represent the standard deviation.
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Since cell–cell fusion was usually only affected by GTPases
when they were present in the same cell as the viral
glycoproteins, we tested the effect of the constitutively active
GTPases on the surface expression of the viral F proteins, as
changes in surface expression are known to affect paramyxo-
virus fusion (Dutch et al., 1998). The analysis was performed in
the absence of the viral attachment proteins, G or HN, to
prevent excessive syncytia formation. We determined before-
hand that the absence of the attachment protein did not affect
surface expression of the fusion protein (data not shown). SV5
F still causes syncytia in the absence of HN, so cells transfectedFig. 7. Immunofluorescence of SV5 glycoprotein-induced syncytia in BHK cells.
permeabilized with 1% Triton X-100, and labeled with primary antibody to the Myc-
with rhodamine phalloidin to stain F-actin. Cells were mounted with a DAPI stain to th
the main text. (B) Examples of the nuclear arrangement and actin structure promotewith SV5 F were incubated at 30 °C prior to analysis to further
inhibit fusion. Flow cytometry analysis of SV5 F and Hendra F
cell surface expression in BHK and Vero cells revealed only
modest changes in F protein surface density when co-expressed
with constitutively active GTPases. These changes do not
correlate with changes in fusion and are not likely large enough
to account for the altered fusion efficiency (Fig. 6). For
example, SV5 F surface density in the presence of Rac1V12 was
reduced by approximately 20% in BHK cells (Fig. 6A), yet
syncytia formation by SV5 was greatly enhanced in the
presence of Rac1V12 in these cells (Fig. 1A). Surface
expression of SV5 F was also reduced by Rac1V12 expression
in Vero cells, but there was little to no change in Vero cells that(A) Products of SV5 syncytia assays were fixed with 4% paraformaldehyde,
tagged GTPase. The FITC-conjugated secondary antibody was applied together
e nuclei. Images were contrast enhanced. Arrows indicate structures described in
d by Cdc42V12 in Hendra or SV5 glycoprotein-induced syncytia.
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expression of Hendra F in the presence of Rac1V12 was
unchanged in BHK and Vero cells, while RhoAL63 and
Cdc42V12 caused a similar decrease in Hendra F expression
in both cell types (Fig. 6B). RhoAL63 decreased fusion by
Hendra glycoproteins, but Cdc42V12 did not (Figs. 1A and 2A),
indicating Hendra F protein expression does not correlate with
the fusion changes observed.
Immunofluorescence
In order to confirm that the constitutively active Rho family
GTPases were causing changes to the actin cytoskeleton
consistent with what has been described in the literature, we
performed immunofluorescence of syncytia that were fixed and
permeabilized. F-actin was stained with rhodamine phalloidin,
the GTPases could be visualized with antibodies to their Myc
tag, and nuclei were stained with DAPI. The effect of
constitutively active GTPases on Hendra and SV5 glycopro-
tein-induced syncytia in both BHK and Vero cells were
examined, and Fig. 7A (SV5 in BHK cells) is representative
of each, as constitutively active GTPases consistently induced
similar actin morphologies. Changes to the cytoskeleton that are
consistent with earlier reports for constitutively active Rac1,
RhoA, and Cdc42 were easily observed (Fig. 7A). Syncytia that
formed as a result of viral glycoprotein expression in the
absence of a GTPase displayed long, thin stress fibers (stiff actin
bundles) nearer to the cell edges, as well as short, dispersed
actin filaments nearer to the center of the cell (Fig. 7A, row one,
panel one). In the presence of Rac1V12, actin localized most
prominently at the cell periphery, and membrane ruffles were
apparent (Fig. 7A, row two, panel one). Rac1V12 co-localized
with actin in the ruffles, and Rac1V12 also localized to the cell
center with nuclei. RhoAL63 clearly induced thick stress fibers
in syncytia, and these often appeared to radiate from the nuclear
region (Fig. 7A, row three, panel one). RhoAL63 appeared to
localize predominantly at the cell center with a declining
distribution toward the cell periphery. Intracellular actin
structures in the presence of Cdc42V12 appeared short and
diffuse (Fig. 7A, row four, panel one). In addition, short
filopodia as well as very long protrusions extending from the
plasma membrane were often visible (Fig. 7B, panels one and
two). The GTPase localized most prominently around the
nuclei, which were usually found in distinctive circular
arrangements (Fig. 7B).
Discussion
Our work suggests that alterations to the actin cytoskeleton
mediated by constitutively active Rac1 or Cdc42 can increase
the number of successful cell–cell fusion events promoted by
paramyxovirus glycoproteins. In addition, active RhoA can
inhibit cell–cell fusion. Our work also demonstrates, however,
that each of the effects of constitutively activated GTPases is
dependent on both the viral system and the cell type employed
(summarized in Table 1). Also, the cell containing the viral
glycoproteins, and not its target cell, appears to convey theinfluence of active GTPases on membrane fusion between two
cell populations, with the exception of Cdc42V12 in certain cell
types.
Rho family GTPases are often activated downstream of
growth factor receptors and adhesion molecules, and their
activation can result in cell migration or adhesion complex
formation via the polymerization of actin (Braga, 2002;
Burridge and Wennerberg, 2004; DeMali et al., 2003;
Raftopoulou and Hall, 2004). Both Rac1 and Cdc42 induce
the polymerization of actin, resulting in protrusion of the plasma
membrane, and they are also recruited to cadherin–cadherin
contact sites between cells and assist in the formation of
adherens junctions (Vasioukhin et al., 2000). This effect of Rac1
and Cdc42 might increase the frequency of fusion promoted by
viral glycoproteins by increasing the likelihood that viral
glycoproteins come in contact with a target membrane or by
stabilizing membrane contacts. However, if this was true, then
we would expect to see the same increase in fusion when the
target cell was transfected with the GTPase that was seen when
the effector cell was transfected. Moreover, RhoA is also
necessary for the formation of adherens junction (Perez-Moreno
et al., 2003), although its role is less clear, and RhoA caused
decreased fusion. The Rho family GTPases have also been
shown to affect gene transcription, and the efficiency of
paramyxovirus F-mediated fusion is affected by the surface
density of the F protein (Dutch et al., 1998). We measured only
minor changes in luciferase expression and surface expression
of the viral F protein when cells were co-transfected with
different GTPases, and fusion data did not correlate with
luciferase or F protein surface expression. Therefore, it is
unlikely that changes in transcription or protein surface
expression account for the effects of GTPases on membrane
fusion. However, our data cannot rule out an effect due to
changes in local density of the F protein by GTPases. An
alternative mechanism explaining the effects of GTPases on F
protein-mediated membrane fusion is one in which the cortical
actin structures generated through the activation of Rac1,
Cdc42, and RhoA decrease or increase the energetic barrier to
membrane fusion, potentially by affecting membrane tension.
Membrane fusion, as occurs between the envelope of viruses
and host cell membranes or between two cell membranes,
requires the expenditure of energy. The energy needed for viral-
mediated membrane fusion is primarily provided by the F
protein conformational change, and evidence suggests that viral
membrane fusion proceeds through intermediates that require
progressively more energy to overcome (Cohen and Melikyan,
2004). The final step, pore enlargement, has the largest energy
barrier, and cortical actin, with its intimate ties to the membrane,
could affect fusion by either promoting or restraining pore
formation and/or pore enlargement. In support of this
hypothesis, recent work in our laboratory suggests that a defect
in pore enlargement created by truncation of the SV5 F
cytoplasmic tail can be partially rescued by treatment of cells
with actin-targeted drugs (Wurth et al., manuscript in
preparation). Since our data suggest that alterations to the
effector cell actin cytoskeleton are more likely to affect fusion
than the target cell, further studies are needed to understand the
331R.M. Schowalter et al. / Virology 350 (2006) 323–334contribution of actin dynamics in effector cells versus target
cells to the energetics of membrane fusion.
Other viruses, both enveloped and non-enveloped, have been
shown to activate and/or be affected by Rho family GTPases.
Adenovirus and Kaposi's sarcoma-associated herpesvirus are
believed to enter cells through an endocytic route, and Rho
family GTPase activation has been shown to play a role in the
endocytosis of these viruses (Akula et al., 2003; Li et al., 1998;
Ridley, 2000; Sharma-Walia et al., 2004). The role of Rho
family GTPases and actin in the entry of these viruses are likely
different from the role we are investigating, since paramyxo-
virus entry is not dependent on endocytosis (Lamb and
Kolakofsky, 2001). There are no data to suggest that Rho
family GTPases play a role in entry after endocytosis, although
it would be interesting to study the effect of Rho family
GTPases on membrane fusion promoted by pH-driven viral
fusion proteins. Furthermore, there are a number of reports
suggesting that Rho family GTPases or their homologs are
important for non-viral membrane fusion, such as in yeast
vacuole membrane fusion (Eitzen et al., 2001; Muller et al.,
2001), Drosophila myoblast fusion (Chen and Olson, 2005;
Hakeda-Suzuki et al., 2002), and calcium-regulated exocytosis
in PC12 cells (Bader et al., 2004; Gasman et al., 2004).
There have been three recent reports indicating that either
RhoA or Rac1 activation is required for cell–cell fusion
mediated by glycoproteins of enveloped viruses that enter cells
at the plasma membrane (del Real et al., 2004; Gower et al.,
2005; Pontow et al., 2004). It is surprising that both RhoA and
Rac1 could promote fusion, since these proteins induce the
formation of stress fibers and lamellipodia, respectively, and
these actin formations are structurally and functionally quite
different. Also, their activation involves separate pathways
(Burridge and Wennerberg, 2004; Etienne-Manneville and
Hall, 2002; Ridley and Hall, 1992; Ridley et al., 1992). RSV,
like Hendra virus and SV5, is a paramyxovirus, although it is
categorized in a different subfamily. RSV glycoprotein-induced
cell–cell fusion has been shown to be reduced by inhibitors of
RhoA signaling (Gower et al., 2005). This indicates that RhoA
activation is necessary for efficient fusion promoted by RSV,
while our data indicates RhoA activation inhibits fusion
promoted by Hendra viral glycoproteins. Two research groups
examining the effect of Rho family GTPases on vaccinia virus-
expressed HIV Env-mediated cell–cell fusion also came to
different conclusions. One showed that fusion promoted by
HIV Env was inhibited by dominant negative Rac1 (Pontow et
al., 2004), and the other showed dominant negative RhoA
inhibited cell–cell fusion, as well as pseudotyped HIV-1 entry
(del Real et al., 2004). Our data show that the cell type used to
investigate the effect of Rho family GTPases on fusion is also a
strong factor influencing the outcome, and the fusion experi-
ments with HIV Env were conducted in different types of cells.
Rho family GTPases have been shown to respond to stimuli
differently in fibroblasts versus epithelial cells, indicating
distinct signaling pathways exist in different cell types (Ridley
et al., 1999). It may also be important to note that all of the
previous studies mentioned above used recombinant vaccinia
virus to deliver genes in their fusion assay, and vaccinia virusaffects cell morphology by stimulating actin polymerization
(Hall, 2004).
Our data also show that the effect of constitutively active
GTPases on cell–cell fusion is usually mediated through the
effector cell. This is consistent with what was shown for RSV,
but different from what has been found for HIV, in which
dominant negative Rac1 expressed in target cells, but not in
Env-expressing cells, inhibited cell–cell fusion (Pontow et al.,
2004). Furthermore, our work with dominant negative
GTPases indicated that their expression had little effect on
paramyxovirus glycoprotein-mediated cell–cell fusion. Our
findings together with previous reports demonstrate that the
effects of Rho family GTPases on viral glycoprotein-mediated
cell–cell fusion are strongly dependent on both the viral
glycoprotein and the cell type. The optimal cortical actin
environment for efficient fusion promotion may be different for
different viral glycoproteins. The diverse effects of GTPases in
different cells with different viral fusion proteins could also be
a consequence of cell type-specific expression of proteins
associated with Rho family signaling, native cytoskeletal
architecture, or slight differences in the mechanism of fusion
promotion by viral F proteins.
Rac1 and Cdc42 bind and activate several of the same
effector molecules and often appear to have overlapping
functions, so it is not surprising that both tend to enhance
membrane fusion under certain circumstances (Bishop and Hall,
2000). However, for cell migration, Rac1 stimulates leading
edge actin polymerization, while Cdc42 communicates which
direction to move (Etienne-Manneville and Hall, 2002). Very
recently, Cdc42 was implicated in movement of the nucleus
(Gomes et al., 2005; Lee et al., 2005). Images of syncytia in the
presence of constitutively active Cdc42 support a role for Cdc42
in the movement of nuclei. Cdc42 was previously thought to
contribute in maintaining cell polarity by reorienting the
microtubule organizing center (MTOC), which co-localizes
with the Golgi apparatus to the space between the nucleus and
leading edge (Bergmann et al., 1983). However, in two reports
this year, it was shown that Cdc42 actually moves the nucleus
rearward, while the MTOC remains stationary, and this involves
retrograde actin flow (Gomes et al., 2005; Lee et al., 2005). Our
data also support a role for Cdc42 in nuclear rearrangement
since the nuclei in syncytia formed organized rings in the
Cdc42V12-expressing syncytia. This orientation of nuclei might
be important to the survival of fused cells if it places the Golgi
toward the cell periphery, which would allow for efficient
protein maturation through the secretory pathway to continue. If
nuclei were placed at random throughout a syncytium, then their
associated Golgi compartments would cross paths, potentially
leading to inefficient trafficking. Functioning of Cdc42 is
expected to be important for the virus as well, since viral
propagation depends on proper protein production and
trafficking to the membrane.
Our data clearly show that Rho family GTPases have the
potential to modulate viral glycoprotein-mediated membrane
fusion, yet it remains to be determined if endogenous Rho
family GTPases play a role in paramyxovirus entry or syncytia
formation. The recent identification of the Hendra virus entry
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activation in target cells (Bonaparte et al., 2005; Negrete et al.,
2005). EphrinB2 is the membrane-spanning ligand of a tyrosine
kinase receptor that stimulates cell adhesion or migration
through activation of Rho family GTPases. An evaluation of the
signaling capability of ephrin ligands has only just begun, but
the activation of Rho family GTPases has already been
implicated (Noren and Pasquale, 2004). We also showed that
the effect of GTPase activation on viral glycoprotein-induced
fusion is highly specific to both the type of viral glycoprotein
used and the type of cell. Therefore, special attention must be
given to these factors in future studies.
Methods
Cell lines
Vero cells, baby hamster kidney (BHK) cells, and BSR cells
were propagated in Dulbecco's modified Eagle's medium
(DMEM; Gibco Invitrogen, Carlsbad, CA) supplemented with
10% fetal bovine serum (FBS) and 1% penicillin and
streptomycin. BSR cells (provided by Karl-Klaus Conzelmann,
Max Pettenkofer Institut) were derived from BHK cells and
constitutively express the T7 polymerase. BSR growth medium
is supplemented with 0.5 mg/ml G-418 sulfate (Gibco
Invitrogen, Carlsbad, CA) every third passage to select for the
T7-expressing cells.
Plasmid vectors
Vectors containing the Hendra F and G genes were provided
by Lin-fa Wang (Australian Animal Health Laboratory). The
Hendra F and G genes were subcloned from their puc18 and
pGEM vectors, respectively, into the pCAGGS mammalian
expression vector (Niwa et al., 1991) as previously described
(Pager et al., 2004). The plasmids pCAGGS-SV5 F and
pCAGGS-SV5 HN were provided by Robert Lamb (Howard
Hughes Medical Institute, Northwestern University). The
plasmids pCMV5-Rac1V12, pCMV5-RhoAL63, and pCMV5-
Cdc42V12 have a 5′ Myc tag and were provided by Douglas
Andres (University of Kentucky). These genes were sequenced
and modified by QuikChange site-directed mutagenesis (Stra-
tagene) as needed.
Production of anti-Hendra-F antisera
New Zealand White rabbits were genetically immunized
with a mixture of codon-optimized NiV-M (Nipah virus matrix),
HeV-F (Hendra virus fusion), and HeV-G (Hendra virus-
glycoprotein) expression plasmids (Aldevron) using an electro-
poration protocol that results in increased antibody titers
(Tollefsen et al., 2003).
Syncytia assay
Subconfluent monolayers of BHK or Vero cells in 6-well
plates were transiently transfected with pCAGGS-Hendra F (1μg) and pCAGGS-Hendra G (1 μg) or pCAGGS-SV5 F (1 μg)
and pCAGGS-SV5 HN (1 μg) in addition to either pCMV5-
Rac1V12 (0.5 μg), pCMV5-RhoAL63 (0.5 μg), pCMV5-
Cdc42V12 (0.5 μg), or the empty pCAGGS vector (0.5 μg)
using Lipofectamine Plus reagents (Invitrogen) according to the
manufacturer's instructions. Cells were incubated at 37 °C for
approximately 20 h (SV5/BHK cells), 24 h (Hendra/BHK cells),
or 48 h (SV5 and Hendra/Vero cells) post-transfection, and then
digital photographs of syncytia were taken with a Nikon
Coolpix995 camera mounted on a Nikon TS100 inverted phase-
contrast microscope.
Reporter gene fusion assay
The effector cell populations (viral glycoprotein containing;
Vero or BSR cells) in 6-well plates were transfected with
genes for viral glycoproteins (0.8 μg each) and cDNA of a
mutant GTPase (0.5 μg) or empty vector (0.5 μg) using
Lipofectamine Plus reagents (Invitrogen). The target cells,
when BSR cells, in 10-cm dishes (1 dish to be distributed over
4 wells) were transfected with an empty vector (3 μg) or the
cDNA for a constitutively active GTPase (3 μg). Additionally,
Vero cells were transfected with the T7 control plasmid
containing luciferase cDNA under control of the T7 promoter,
whether the effector (0.8 μg/well) or target (2 μg/6-cm dish to
be distributed over 2 wells) cell population. BSR cells
constitutively express the T7 polymerase, thus upon membrane
fusion and content mixing of effector and target cells luciferase
is expressed. As a negative control, effector cells were
transfected with genes for G or HN and luciferase if Vero
cells, then overlayed with target cells (data not shown).
Transfected cells were incubated at 37 °C overnight. The target
cell population was lifted from the plate surface with trypsin,
resuspended in DMEM plus 10% FBS and antibiotics, and
overlayed onto adherent effector cells. Effector cells were
intentionally made to be subconfluent at the time of the
overlay to limit syncytia formation between effector cells.
Combined cells were incubated at 37 °C for 3 h and then
analyzed for luciferase activity using a luciferase assay system
(Promega) according to manufacturer's protocol. Light
emission was measured using an Lmax luminometer (Molec-
ular Devices, Sunnyvale, CA).
Reporter gene expression assay
BSR cells in 6-well plates were co-transfected with the T7
control plasmid containing luciferase cDNA under control of
the T7 promoter (0.8 μg/well) and a constitutively active
GTPase (0.5 μg) or empty vector (0.5 μg) using
Lipofectamine Plus reagents (Invitrogen). Twenty-four hours
after transfection, cells were lysed, and a 1/100 dilution of the
supernatant was analyzed for luciferase activity using the
luciferase assay system (Promega) according to manufacturer's
protocol. Light emission was measured using an Lmax
luminometer (Molecular Devices, Sunnyvale, CA). The
dilution step was necessary to prevent light saturation
measured by the luminometer.
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BHK or Vero cells in 6-cm dishes were transfected with
either SV5 F or Hendra F plasmids (2 μg) and a GTPase (1 μg)
or empty vector (1 μg). After transfection, BHK cells
expressing SV5 F were incubated at 30 °C overnight to prevent
excessive syncytia formation. Hendra F-transfected cells were
incubated at 37 °C overnight because syncytia formation does
not occur in the absence of G. Cells were prepared for flow
cytometry as described previously (Horvath and Lamb, 1992)
with the SV5 F primary monoclonal antibody F1a, provided by
Richard Randall (University of St Andrews, Fife, UK) (Randall
et al., 1987), or polyclonal rabbit antibodies generated against
Hendra F, and the secondary antibody fluorescein isothiocya-
nate (FITC)-conjugated goat anti-mouse (for SV5 F) or anti-
rabbit (for Hendra F) immunoglobulin G (Jackson ImmunoR-
esearch Laboratories, West Grove, PA). Fluorescence intensity
of 10,000 cells was measured by flow cytometry (Flow
Cytometry Core Facility, University of Kentucky).
Immunofluorescence
BHK cells on poly-lysine-coated cover slips placed in 6-well
plates were transfected as in the syncytia assay with SV5
glycoproteins and a constitutively active GTPase or empty
vector. Fifteen hours after transfection and incubation at 37 °C,
cells were fixed in 4% paraformaldehyde for 12 min and
permeabilized with cold 1% Triton X-100 in 4 °C for 15 min.
Myc-tagged constitutively active GTPases were labeled with
primary monoclonal anti-Myc antibody (Oncogene Research
Products, San Diego, CA) and secondary antibody fluorescein
isothiocyanate-conjugated goat anti-mouse immunoglobulin G
(Jackson Immunoresearch Laboratories, West Grove, PA).
Rhodamine phalloidin (Invitrogen) was applied with the
secondary antibody and cover slips were mounted on glass
slides with Vectashield mounting medium plus DAPI to stain
nuclei (Vector Laboratories, Burlingame, CA). Digital images
were collected on a Zeiss Axiovert 200 M inverted fluorescence
microscope (Carl Zeiss MicroImaging, Thornwood, NY) with
an Orca ER camera (Hamamatsu Corporation, Bridgewater, NJ)
using OpenLab imaging software (Improvision, Lexington,
MA).
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